T and NK cells: two sides of tumor immunoevasion

Melanoma Cells Inhibit NK Cell Functions--Letter

(2012) G. Sconocchia et al.   CANCER RESEARCH

Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity

(2012) G. Pietra et al.   CANCER RESEARCH

Cooperativity of adaptive and innate immunity: implications for cancer therapy

(2011) Anil Shanker et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Natural Killer Cells Efficiently Reject Lymphoma Silenced for the Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing

(2011) L. Cifaldi et al.   CANCER RESEARCH

Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives

(2011) J. Godin-Ethier et al.   CLINICAL CANCER RESEARCH

Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine–prostaglandin E2cooperation

(2011) Magis Mandapathil et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Regulation of Immune Responses by Prostaglandin E2

(2011) P. Kalinski   JOURNAL OF IMMUNOLOGY

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis

(2011) Maria Benevolo et al.   Journal of Translational Medicine

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

Multipeptide vaccination in cancer patients

(2009) Lorenzo Pilla et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity

(2009) Anil Shanker et al.   IMMUNOLOGY

NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model

(2009) N. T. Joncker et al.   JOURNAL OF IMMUNOLOGY

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer

(2009) Yan-Fang Gao et al.   Journal of Translational Medicine